Cage Bio closes $7.2 million round of series A funding
The investment was led by professional and angel investor groups consisting of current and former pharmaceutical executives and physicians.
The investment was led by professional and angel investor groups consisting of current and former pharmaceutical executives and physicians.
MBC BioLabs alum, Trevor Martin, is named Executive of the Year 2020 by San Francisco Business Times
XPose Therapeutics and Accelero Biostructures, two of the MBC BioLabs San Carlos resident companies, announced research agreements.
Jupiter Therapeutics and Keyhole Therapeutics are the winners of the Astellas-sponsored "Golden Ticket Competition 2020."
Doug Crawford talks about how the biotech industry has largely been able to thrive amid the pandemic.
Symbiome, the first skincare brand to create a collection of BioIntact™ products to nourish the skin microbiome, has officially launched today.
Symbiome, the first skincare brand to create a collection of BioIntact™ products to nourish the skin microbiome, has officially launched today.